InBios International, Inc.

Ready for a change? InBios is hiring! We are on the hunt for candidates who value a sense of community and cooperation, and are excited to share in our vision of delivering impactful solutions to those affected by infectious diseases. Head over to the career portal to view current openings, and be sure to check back frequently for updates. #Hiring #Careers

The Times of India has issued a Zika virus alert, warning the public of an increase in #Zika virus cases due to the monsoon season, as “dampness becomes the ideal breeding ground for mosquitos.” InBios was an early responder to the 2015-2016 Zika Virus surges in the Americas and abroad with the quick development of an EUA serology kit. Our FDA market authorized Zika IgM ELISA IVD kit has a high relative sensitivity of >90% for samples collected ≥7 days after symptoms onset and relative specificity of 95%. The assay has the added benefit of differentiating Zika IgM positive patients from those infected with other flaviviruses such as West Nile or Dengue. Click the link below to learn more about InBios Zika products, or click the link in the comments below to read the full article.

It’s time to get ready for the annual #ADLM (formerly AACC) conference! From July 28 – August 1, the Association for Diagnostics & Laboratory Medicine will be hosting their annual conference in Chicago, IL. Be sure to head over to InBios’ booth #3252 to learn about our range of diagnostic products for emerging infectious diseases and biothreats. If you would like to set up a meeting, send us a request at inquiries@inbios.com. Register today with the link in the comments.

A sub-district in Malaysia recently confirmed the detection of Burkholderia pseudomallei, the bacteria that causes #melioidosis, in a community rugby field. The local health department reports an increase in melioidosis cases of 12.8% this year as compared to the previous period, advising the public to avoid contaminated soil and water sources. To read the full article, click the link below.

NBC news reports that cases of COVID-19 “aren’t declining anywhere in the US,” suggesting the possible start of the summer wave. With concerns that “cases will continue to rise as people retreat indoors to escape… the heat wave,” now is the time to stock up on at-home COVID test kits. Click the link below to view InBios’ rapid COVID test kits, or click the link in the comments to read the full article.

Las Vegas is preparing for “huge numbers of mosquitos… a concerning number of them carrying the West Nile virus”, as a Nevada environmental health supervisor warns. Though the city’s most recent outbreak occurred five years ago, resulting in 43 cases, officials are “concerned that this summer could be far worse,” according to an NBC news report. Click the link in the comments below to learn more, or click below to view InBios West Nile products.

The CDC has recently issued a Health Alert Network (HAN) Health Advisory to inform the public that dengue virus infections hold an increased level of risk this year in the United States. InBios is prepared and stocked with our trusted FDA cleared dengue diagnostics. Clink the link in the comments below to explore InBios’ product line.

With the annual return of West Nile virus, Forbes has published a quick sheet of key facts to remind the public of signs and symptoms to watch out for this summer. These warnings "have been happening weeks earlier than usual on account of the milder winter and spring... bringing an early mosquito season." Read the full article by clicking the link below. #WestNile

The @WHO will be hosting a webinar on the importance of foodborne Chagas disease at 6:30am PST / 9:30am EST tomorrow, June 25th. Although this neglected tropical disease can be transmitted by many routes, foodborne transmission "has been associated with more severe symptoms than usually occur with vector-borne transmission." Click the link below to register. #Chagas

The Sambalpur district of India has prepared to prevent lymphatic #filariasis with a Mass Drug Administration campaign scheduled for later this year. The plan involves a focus on the “T3” strategy: test, treat, track. Click the link below for the full article.